# Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

> **NCT06478407** · — · RECRUITING · sponsor: **Li Xiaorong** · enrollment: 18000 (estimated)

## Conditions studied

- Diabetic Retinopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06478407
- **Lead sponsor:** Li Xiaorong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-28
- **Primary completion:** 2025-03-28
- **Final completion:** 2025-03-28
- **Target enrollment:** 18000 (ESTIMATED)
- **Last updated:** 2024-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06478407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06478407, "Community Screening Study of Diabetic Retinopathy in Tianjin in 2024". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06478407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*